Fremanezumab

Biologics License Application Submitted for Fremanezumab for Migraine Prevention

Biologics License Application Submitted for Fremanezumab for Migraine Prevention

By

Teva announced the submission of a Biologics License Application to the FDA for fremanezumab for the prevention of migraine.

Sign Up for Free e-Newsletters